Survey finds 89% of women unaware of existing OTC UTI treatments.
This article was originally published in The Tan Sheet
Executive Summary
OTC UTI ANALGESIC AVAILABILITY RECOGNIZED BY 25% OF WOMEN in a recent survey sponsored by OTC drug and device manufacturer PolyMedica. The survey, which involved 250 women (ages 18-54) who had suffered from urinary tract infections, found that 63% of the women were "unaware" that over-the-counter UTI treatments existed and 12% were "unsure whether such products were available." Woburn, Mass.-based PolyMedica markets a number of OTC UTI remedies, including the Azo-Standard brand analgesic.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning